share_log

AbbVie | 4: Statement of changes in beneficial ownership of securities-Officer GONZALEZ RICHARD A

AbbVie | 4: Statement of changes in beneficial ownership of securities-Officer GONZALEZ RICHARD A

艾伯維公司 | 4:持股變動聲明-高管 GONZALEZ RICHARD A
美股SEC公告 ·  08/07 17:02

Moomoo AI 已提取核心訊息

Richard A. Gonzalez, Executive Chairman of the Board at AbbVie Inc. [ABBV], completed a sale of 66,500 shares of common stock on August 5, 2024. The transaction was carried out in the open market with the shares sold at a price of $186.52 each, resulting in a total market value of $12,403,580. Following the sale, Gonzalez directly holds 446,599 shares of AbbVie's common stock.
Richard A. Gonzalez, Executive Chairman of the Board at AbbVie Inc. [ABBV], completed a sale of 66,500 shares of common stock on August 5, 2024. The transaction was carried out in the open market with the shares sold at a price of $186.52 each, resulting in a total market value of $12,403,580. Following the sale, Gonzalez directly holds 446,599 shares of AbbVie's common stock.
艾伯維公司董事會執行主席Richard A. Gonzalez於2024年8月5日完成了一筆共計66,500股普通股的交易。此交易在公開市場進行,每股售價爲186.52美元,總市值爲12,403,580美元。出售後,Gonzalez直接持有446,599股艾伯維公司的普通股。
艾伯維公司董事會執行主席Richard A. Gonzalez於2024年8月5日完成了一筆共計66,500股普通股的交易。此交易在公開市場進行,每股售價爲186.52美元,總市值爲12,403,580美元。出售後,Gonzalez直接持有446,599股艾伯維公司的普通股。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息